rs2239587

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002775.5(HTRA1):​c.777+167G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 151,934 control chromosomes in the GnomAD database, including 1,955 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.15 ( 1955 hom., cov: 32)

Consequence

HTRA1
NM_002775.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.176

Publications

3 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 10-122489793-G-A is Benign according to our data. Variant chr10-122489793-G-A is described in ClinVar as Benign. ClinVar VariationId is 1245621.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.353 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTRA1NM_002775.5 linkc.777+167G>A intron_variant Intron 3 of 8 ENST00000368984.8 NP_002766.1 Q92743

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTRA1ENST00000368984.8 linkc.777+167G>A intron_variant Intron 3 of 8 1 NM_002775.5 ENSP00000357980.3 Q92743
HTRA1ENST00000648167.1 linkc.459+167G>A intron_variant Intron 3 of 8 ENSP00000498033.1 A0A3B3IU24

Frequencies

GnomAD3 genomes
AF:
0.148
AC:
22401
AN:
151816
Hom.:
1948
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.296
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.132
Gnomad EAS
AF:
0.366
Gnomad SAS
AF:
0.341
Gnomad FIN
AF:
0.0905
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.111
Gnomad OTH
AF:
0.158
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.148
AC:
22445
AN:
151934
Hom.:
1955
Cov.:
32
AF XY:
0.152
AC XY:
11316
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.161
AC:
6676
AN:
41418
American (AMR)
AF:
0.170
AC:
2598
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.132
AC:
459
AN:
3468
East Asian (EAS)
AF:
0.367
AC:
1893
AN:
5162
South Asian (SAS)
AF:
0.342
AC:
1638
AN:
4790
European-Finnish (FIN)
AF:
0.0905
AC:
957
AN:
10574
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.111
AC:
7569
AN:
67942
Other (OTH)
AF:
0.160
AC:
337
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
940
1880
2819
3759
4699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.144
Hom.:
555
Bravo
AF:
0.153
Asia WGS
AF:
0.320
AC:
1116
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.3
DANN
Benign
0.61
PhyloP100
-0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239587; hg19: chr10-124249309; COSMIC: COSV64565254; API